Page 79 - IJB-5-2
        P. 79
     Arab W, et al.
           and  illness  or  injury,  which  influence  the  balance  of   3D  bioprinting  system [27,28]   to  fabricate  3D  scaffolds
           protein  synthesis  and  degradation .  Skeletal  muscle   for the differentiation of myoblast cells. The process of
                                         [6]
           is  a  voluntary  moveable  tissue  that  has  the  ability  to   3D  bioprinting  is  believed  to  enhance  the  arrangement
           convert chemical energy into mechanical energy and then   of  homogeneous  cellular  scaffolds  and  improve  cell
           transfer  it  to  tendon  tissue.  It  also  supports  soft  tissue   proliferation  and  adhesion  for  myotube  formation. Two
           and maintains body posture . In addition, this tissue is   sequences  of  self-assembling  peptides  are  tested  and
                                  [7]
           responsible  for  different  functions  of  the  body  such  as   analyzed for cell viability, proliferation, and differentiation.
           respiration and protection of abdominal viscera, and also   The promising results indicate that 3D bioprinting of self-
           controls the movement of limbs . Skeletal muscle tissue   assembling ultrashort peptides may valuably improve the
                                     [8]
           exhibits  the  native  capability  to  regenerate  and  repair   process of muscle tissue engineering.
           through the activation of local satellite cells [8,9] .
             However,  this  ability  declines  with  age  as  well  as  in   2. Materials and Methods
           clinical conditions such as tumor resection and traumatic   Two  tetrameric  self-assembling  peptides  CH-01  and
           sport  injuries  including  concussions  and  strains,  and   CH-02  were  custom-synthesized  in  our  Laboratory  for
           muscular dystrophy that may result in volumetric muscle   Nanomedicine.  Mouse  myoblast  cells  (C2C12)  were
           loss (VML). In these injuries, approximately 20% or more   obtained  from  ATCC,  USA.  The  following  materials
           of  the  muscle  mass  is  lost [10,11]   and,  as  a  result,  tissues   were  ordered  from  Gibco,  USA:  Dulbecco’s  modified
           lose the ability to signal each other and become unable to   eagle medium (DMEM), fetal bovine serum (FBS), heat-
           repair themselves through natural physiological processes.   inactivated horse serum, Dulbecco’s phosphate-buffered
           Thus, surgical intervention is needed [12-15]  to restore normal   saline  (PBS)  solution,  and  penicillin-streptomycin
           function  and  prevent    the  formation  of  scar  tissue ,   (P/S)  antibiotics.  An  3-(4,5-Dimethylthiazol-2-yl)-2,5-
                                                        [13]
           which  may  lead  to  muscle  atrophy  and  prevent  muscle   diphenyltetrazolium  bromide  (MTT)  cell  proliferation
           regeneration . Around the world, millions of people are   assay  kit  and  a  LIVE/DEAD  Viability/Cytotoxicity  kit
                     [16]
           affected by these clinical conditions which cause significant   were  purchased  from  Promega,  USA.  Immunostaining
           social  and  economic  problems [17,18] . As  such,  alternative   antibody  myosin  heavy  chain  (MHC)  was  purchased
           technologies are urgently needed for the reconstruction of   from Abcam. Cell culture flasks and 96-well plates were
           skeletal  muscle  tissues  that  have  experienced VML  and   ordered from Corning, USA.
           need to regenerate new functional tissue [10,19] .
             An  alternative  approach  for  VML  treatment  and   2.1. Preparation of Peptide Hydrogel
           organ  fabrication  is  tissue  engineering  through  the  use   CH-01  and  CH-02  peptide  powders  were  dissolved  in
           of biological scaffolds . The process of muscle tissue   Milli-Q water. Then, 10× PBS was mixed into the peptide
                              [20]
           engineering is the same as that of skin tissue engineering:   solution. Gelation of both peptides occurred within a few
           The  cells  are  grown  in  a  three-dimensional  (3D)   minutes  at  a  minimum  concentration  of  4  mg/mL  and
           environment,  similar  to  how  they  would  grow  in vivo
           using  biomaterial  scaffolds.  Particular  interest  is  taken
           in scaffolds made from self- assembling peptides for 3D
           culture  and  bioprinting  because  of  their  synthetic,  yet
           natural background. They have been used as biomaterials
           and matrices to deliver encapsulated bioactive molecules
           in therapeutic applications and regenerative medicine [21-25] .
           Many hydrogels have been used and assessed for their
           mechanical  properties,  cellular  activity,  and  myogenic
           potential. However, a need is still present to develop the
           most appropriate material that is efficient in maintaining
           mechanical stability and promoting myotube formation .
                                                        [26]
             The principle of 3D bioprinting allows the capability of
           fabricating constructs of a fully customized muscle. This
           technology  depends  on  forming  a  complex  biological
           construct  by  dispensing  cells  and  bionics  in  a  layer-
           by-layer  fashion.  Due  to  these  excellent  features,  3D
           bioprinting  has  become  the  ultimate  solution  for  tissue   Figure  1.  The  self-assembling  peptides  CH-01  (4  mg/ml)  and
           engineering,  especially  when  reconstructing  skeletal   CH-02 (3 mg/ml) generate macromolecular nanofibrous hydrogels
           muscles. Inspired by this emerging technology,  we aim   in an aqueous solution, the gelation was enhanced using phosphate
           to study the printability of our custom-designed robotic   buffer saline.
                                       International Journal of Bioprinting (2019)–Volume 5, Issue 2        75





